🇺🇸 FDA
Patent

US 11077079

GHB formulation and method for its manufacture

granted A61KA61K31/19A61K31/785

Quick answer

US patent 11077079 (GHB formulation and method for its manufacture) held by Jazz Pharmaceuticals Ireland Limited expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/19, A61K31/785, A61K38/02, A61K9/10